ChinaAnticoagulantInjection DESCRIPTION Rivaroxaban, a factor Xa inhibitor, is the active ingredient in RIVAROXABAN Tablets with the chemical name 5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5yl}methyl)-2-thiophenecarboxamide. The molecular formula of rivaroxaban is C19H18ClN3O5S and the molecular weight is 435.89. The structural formula is: Rivaroxaban is a pure (S)-enantiomer. It is an odorless, non-hygroscopic, white to yellowish powder. Rivaroxaban is only slightly soluble in organic solvents (e.g., acetone, poly ethylene glycol 400) and is practically insoluble in water and aqueous media. Each RIVAROXABAN tablet contains 10 mg, 15 mg, or 20 mg of rivaroxaban. The inactive ingredients of RIVAROXABAN are: croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and sodium lauryl sulfate. Additionally, theproprietary film coating mixture used for RIVAROXABAN 10 mg tablets is Opadry鈭€ Pink and RIVAROXABAN 15 mg tablets is Opadry鈭€ Red, containing ferric oxide red, hypromellose, polyethylene glycol 3350, and titanium dioxide, and for RIVAROXABAN 20 mg tablets is Opadry鈭€ II Dark Red, containing ferric oxide red, polyethylene glycol 3350, polyvinyl alcohol (partially hydrolyzed), talc, and titanium dioxide. Mechanism of Action XARELTO is an orally bioavailable factor Xa inhibitor that to reduce the risk of stroke and systemic embolism in patients e white blood cell-boosting special drug-Jilifen (rhG-CSF), breaking the market monopoly by American and Japanese manufacturers and gaining the reputation of "China's first injection". For more than two decades, Jiuyuan Gene has successively launched Ji Lifen, Ji Pai Lin, Ji Jufen, Yi Zhe Jia, Ji Ou Ting and Bone Youdao series of products. In 2020, the company's R&D center and some production lines settled in Hangzhou Pharmaceutical Town, and the level of R&D and production of software and hardware has been effectively improved. With the help of academician expert workstations, post-doctoral workstations and other scientific research platforms, Jiuyuan vigorously develops the research and development of macromolecular drugs focusing on insulin and monoclonal antibodies. Based on the product positioning of both innovative drugs and generic drugs, as well as biological drugs and chemical drugs, the company focuses on the development of new drugs in the fields of ong professional technical team ensure to produce the top quality products. 4. Special cost control system ensure to provide the most favorable price. 5. Rich experience on drug.ChinaAnticoagulantInjection website:http://www.jiuyuangene.net/finished-dosage-form/anticoagulant-injection/